Patent · US Active

Methods for antibody production

US8298823B2 · kind B2 · utility

26Cited by
13References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2010
Grant dateOct 30, 2012
Priority date
Expiry dateDec 25, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2535/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.